Of the top 20, Novo and Lilly were among only six companies that witnessed declines in their market value in the third ...

Despite a mission to become a dominant cancer drug player, Gilead Sciences has as of late been locked in on its ...

Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the ...

After an activist investor revolted against the leadership team at Aurinia Pharmaceuticals, the CEO in question is resorting ...

An FDA expansion of Sarepta Therapeutics’ Duchenne muscular dystrophy (DMD) Elevidys has sparked a new surge in sales for the ...

Just days after laying out $90 million to acquire Nektar Therapeutics’ Alabama manufacturing plant, Ampersand Capital ...

After unveiling a corporate austerity program earlier this year, Germany's Evotec is selling off a piece of its CDMO business ...

AbbVie is reaching for the Sky(rizi) as it spent a staggering $51.5 million on TV drug ads for its immunology blockbuster in October. | AbbVie is reaching for the Sky(rizi) as it spent a staggering ...

Emerging from the rough waters of the CDMO industry with a new chief executive at the helm, AGC Biologics is on a mission to reinvent itself as a manufacturing partner defined by friendliness and e | ...

On Tuesday night, millions of Americans watched as former president Donald J. Trump gathered up enough electoral votes needed ...

Novavax has inked another settlement for a past COVID-19 vaccine supply deal. | Novavax has inked another settlement for a ...

As other biopharma giants have divested their generics units to focus on the development and commercialization of innovative ...